close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Big Pharma Just Put Peptides Back on the Map – Which Players Are Still Under the Radar?
Via AB Newswire
Tickers ENTX LLY PTGX
Exposures Product Safety
Capricorn Buys New Stake in Ionis Pharmaceuticals (IONS) With 163,000 Shares
Via The Motley Fool
Tickers IONS MSFT REAL TARS VERA WAY
Exposures Product Safety
Why Replimune Stock Was Soaring Today
Via The Motley Fool
Tickers BMY REPL
Exposures Product Safety
Why QuidelOrtho (QDEL) Stock Is Up Today
Via StockStory
Topics Economy Government World Trade
Tickers KO MSFT QDEL
Exposures Political Product Safety Supply Chain
Achieve Life Sciences Stock Soars On Receiving FDA Voucher For Expediting Review Of Investigational Drug In Vaping Cessation
Via Stocktwits
Tickers ACHV IWC VXF
Exposures Product Safety
Why Are Natera (NTRA) Shares Soaring Today
Via StockStory
Topics Intellectual Property
Tickers AAPL MSFT NTRA WFC
Exposures Intellectual Property Product Safety
Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target
Via Newsfile
Tickers OSRH
Exposures Product Safety
Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know
Via StockStory
Tickers BAC HIMS
Exposures Product Safety
Top 1% Celcuity Shoots To Record High On Roche-Rivaling Breast Cancer Results
Via Investor's Business Daily
Topics Government
Tickers CELC LLY RHHBY
Exposures Political Product Safety
Class Action Filed Against aTyr Pharma, Inc. (ATYR) - December 8, 2025 Deadline to Join - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Tickers ATYR
Exposures Financial Legal Product Safety
Class Action Filed Against aTyr Pharma, Inc. (ATYR) - December 8, 2025 Deadline to Join - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers ATYR
Exposures Financial Legal Product Safety
Class Action Filed Against Savara Inc. (SVRA) - November 7, 2025 Deadline to Join - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
Class Action Filed Against Savara Inc. (SVRA) - November 7, 2025 Deadline to Join - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
Investors in Cytokinetics, Incorporated Should Contact Levi &amp; Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
Tickers CYTK
Exposures Financial Legal Product Safety
Investors in Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
Via NewMediaWire
Topics Earnings Fraud Lawsuit
Tickers CYTK
Exposures Financial Legal Product Safety
Summit Therapeutics Inc (NASDAQ:SMMT) Reports Wider-Than-Expected Q3 2025 Loss
Via Chartmill
Tickers SMMT
Exposures Product Safety
Corcept Therapeutics Stock Slips Premarket Despite Strong Cancer Trial Data Showing 40% Drop In Disease Progression Risk
Via Stocktwits
Tickers CORT
Exposures Product Safety
Biotech Boom: Strategic Realignments and AI Integration Fuel Investor Focus, Signaling Broader Market Shifts
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Tickers GILD JNJ MRK MRNA PFE QQQ
Exposures Artificial Intelligence Intellectual Property Interest Rates
Healthcare’s AI Revolution: Generative Intelligence Delivers Real Returns as Agentic Systems Drive Measurable Outcomes
Via TokenRing AI
Topics Artificial Intelligence Economy
Tickers AMZN BFLY EXAI GOOGL GSK IBM
Exposures Artificial Intelligence Economy Product Safety
Kezar Launches Strategic Review As FDA Roadblock Derails Liver Drug Plans
Via Benzinga
Tickers KZR
Exposures Product Safety
NetworkNewsBreaks – Oncotelic Therapeutics Inc. (OTLC) Positioned to Fill Critical Gaps in Cancer Care with RNA and Small-Molecule Therapies
Via Investor Brand Network
Topics Intellectual Property
Tickers OTLC
Exposures Intellectual Property Product Safety
Kezar Life Sciences Stock Hit With Downgrades And Price Target Cuts: Retail Keeps Hopes Alive
Via Stocktwits
Topics Workforce
Tickers DFAS IWC KZR WFC
Exposures Layoff Product Safety
Why Is Taysha Gene Therapies Stock Falling Friday?
Via Benzinga
Tickers ALPMF ALPMY TSHA
Exposures Product Safety
CollaVita Collagen Announces Commitment to Quality Standards Through Third-Party Certifications
Via Press Advantage
Topics Supply Chain
Exposures Product Safety Supply Chain
CYTK INVESTOR ALERT: Bronstein, Gewirtz &amp; Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CYTK
Exposures Financial Legal Product Safety
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CYTK
Exposures Financial Legal Product Safety
Artiva Biotherapeutics Gets A Price Target Hike From Wedbush: Stock Rallies 99% But Retail Expects Further Rally
Via Stocktwits
Tickers ARTV BIB IBBQ TSLA
Exposures Product Safety
Turnstone Biologics: A $100 Dream Collides with a $0.34 Reality
Via MarketMinute
Topics Intellectual Property Workforce
Tickers IOVA XOMA
Exposures Intellectual Property Layoff Product Safety
The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly.
Via Investor's Business Daily
Tickers ACHV IRON REGN RVMD RY TSX:RY
Exposures Product Safety
FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times
Via Benzinga
Tickers ACHV IRON MKGAF MKKGY REGN RVMD
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today